Gam Holding Ag Exelixis, Inc. Transaction History
Gam Holding Ag
- $1.32 Billion
- Q1 2024
Shares
2 transactions
Others Institutions Holding EXEL
# of Institutions
462Shares Held
246MCall Options Held
1.7MPut Options Held
1.02M-
Black Rock Inc. New York, NY34.9MShares$769 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA30.8MShares$680 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA26.7MShares$588 Million2.95% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.1MShares$333 Million0.56% of portfolio
-
State Street Corp Boston, MA13.1MShares$288 Million0.01% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $7.1B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...